FDA warns that pioglitazone may increase the risk of bladder cancer recurrence

Diagram of a male bladder

The US Food and Drug Administration reports that use of the diabetes medication pioglitazone for more than one year may be associated with an increased risk of bladder cancer. Pioglitazone (known as Actos in the UK and US) is a thiazolidinedione or glitazone that is used in type 2 diabetes to reduce insulin resistance. Review [read the full story…]